Per2 attenuates LPS-induced chondrocyte injury through the PTEN/PI3K/Akt signalling pathway

Yu Zhao1, Ding Ma1, Bingchen Dong1

  • 1Depatment of Orthopaedics, Xi'an Ninth Hospital, Xi'an 710054, Shaanxi Province, PR China.

Bioscience Reports
|May 20, 2020
PubMed

Insights

Period circadian clock 2 (Per2) plays a key role in osteoarthritis (OA) by promoting cell proliferation and inhibiting apoptosis and inflammation. Per2 activates the PTEN/PI3K/Akt pathway, suggesting it as a therapeutic target for OA.

Area of Science:

  • Molecular Biology
  • Chronobiology
  • Osteoarthritis Research

Background:

  • Osteoarthritis (OA) is a degenerative joint disease with complex mechanisms.
  • The role of circadian clock genes, such as period circadian clock 2 (Per2), in OA pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the function of Per2 in osteoarthritis.
  • To elucidate the molecular mechanisms underlying Per2's role in OA, particularly its interaction with the PTEN/PI3K/Akt signaling pathway.

Main Methods:

  • Reduced Per2 expression in human chondrocytes (NHAC-kn) using lipopolysaccharide (LPS).
  • Manipulated Per2 levels using pcDNA3.1-Per2 (overexpression) and si-Per2 (knockdown).
  • Assessed cell proliferation (MTT assay), apoptosis, inflammation (ELISA), and protein interactions (CO-IP).
  • Investigated the PTEN/PI3K/Akt pathway activation using IGF-1.

Main Results:

  • LPS treatment decreased Per2 mRNA and protein levels in NHAC-kn cells.
  • Per2 overexpression enhanced cell proliferation, inhibited apoptosis, and reduced inflammation.
  • Per2 specifically bound to PTEN, activating the PTEN/PI3K/Akt signaling pathway.
  • Per2's anti-inflammatory effects in LPS-stimulated cells were mediated via this pathway.

Conclusions:

  • Per2 plays a protective role in osteoarthritis by promoting chondrocyte proliferation and suppressing apoptosis and inflammation.
  • Per2 exerts its effects by activating the PTEN/PI3K/Akt signaling pathway.
  • Per2 represents a potential novel therapeutic target for osteoarthritis treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K